TerminatedInterventionalNot ApplicableUpdated Nov 18, 2023
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality | NCT02378337 | Trialant
CompletedObservationalUpdated Nov 28, 2017
Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality
ClinicalTrials.gov ID
NCT02378337
Lead Sponsor
Hospital Sao RafaelOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
335Actual
Last Update Posted
Nov 28, 2017Actual
Start Date
Sep 2014Actual
Primary Completion Date
Aug 2015Actual
Completion Date
Mar 2016Actual
Brief Summary
Identify the best combination of predictive variables that influence ionizing radiation dose and improved image quality through analysis and quantification of PET-CT images in simulators and patients.
Malignant Neoplasm of Breast
Hodgkin Disease
Non-Hodgkin Lymphoma, Follicular (Nodular)
Malignant Neoplasm of Bronchus and Lung
Malignant Neoplasm of Colon
Secondary Neoplasm Malignant and Unspecified Lymph Nodes
Malignant Melanoma of the Skin
Malignant Neoplasm of Small Intestine
Image quantify
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Healthy volunteers;
Both genders;
Age over 18 years;
Clinical indication for PET-CT scan.
Exclusion Criteria:
Pregnant women;
Patients who have lesions in the liver metabolically active whether primary or metastatic;